McKesson Corporation

By default your notes are visible only to you.

637.0

52-week range

999.0

742.44

Your model inputs

Required return / cost of capital

FCFF terminal growth rate

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Valuation

Free Cash Flow Yield

FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per share

6.5 %

Dividend Yield TTM

0.4 %

Market cap $

$ 89,244

Price / Earnings TTM

P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per share

19.3

Price / Book TTM

(41.7)

PEG TTM

Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rate

0.4

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

4.5 %

291.5 %

319.3 %

Free cash flow per share growth

13 %

89.7 %

258.5 %

Earnings per share growth

49.2 %

242 %

295.7 %

Founded: 1,833

Employees: 44,000

Business Summary:McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Fair Value Reference Estimate